PTC Therapeutics (PTCT) – Hot Corp. News
-
PTC Therapeutics (PTCT) Releases Copy of Slide Deck on Trial of Study 041 for Translarna
-
PTC Therapeutics (PTCT) Announces FDA Approval of Evrysdi for Spinal Muscular Atrophy in Adults and Children 2 months and older
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to PTCT Stock Lookup